2025. Repurposing FDA-Approved Antimalarial Drugs: Mefloquine as a Promising Multi-Targeted Therapeutic for Non-Small Cell Lung Cancer: Repurposing Antimalarials: Mefloquine for Multi-Targeted NSCLC Therapy. Indian Journal of Chemistry (IJC). 64, 7 (Jul. 2025), 730–745. DOI:https://doi.org/10.56042/ijc.v64i7.16642.